drugset / Trial / NCT07187011
Initial Study Sesting Efficacy and Tolerability of PT150 for PTSD in Veterans
Phase 2
Not yet recruiting
120 enrolled
San Diego Veterans Healthcare System
Pop Test Oncology LLC · collabUnited States Department of Defense · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to test the drug PT150, which blocks glucocorticoid receptor (GR) signaling, for treatment of PTSD in Veterans, and establish a safety and efficacy profile that will inform the design of future studies.
Timeline
- Start
- 2026-04-01
- Primary completion
- 2029-03-01
- Completion
- 2029-05-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ORG 34517 | Small molecule | 900 mg | — |